These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33581212)

  • 1. Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
    Patel MC; Chesnokov A; Jones J; Mishin VP; De La Cruz JA; Nguyen HT; Zanders N; Wentworth DE; Davis TC; Gubareva LV
    Antiviral Res; 2021 Apr; 188():105035. PubMed ID: 33581212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase.
    Gregor J; Radilová K; Brynda J; Fanfrlík J; Konvalinka J; Kožíšek M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33673017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir.
    Soh YQS; Malone KD; Eguia RT; Bloom JD
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
    Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
    J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection.
    Zhang H; Zhou L; Amichai S; Zandi K; Cox B; Schinazi R; Amblard F
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126639. PubMed ID: 31493987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan.
    Chon I; Wagatsuma K; Saito R; Tang JW; Isamu S; Suzuki E; Shirahige Y; Kawashima T; Minato M; Kodo N; Masaki H; Hamabata H; Yoshioka S; Ichikawa Y; Sun Y; Li J; Otoguto T; Watanabe H
    Antiviral Res; 2024 Sep; 229():105956. PubMed ID: 38969237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons.
    Gubareva LV; Mishin VP; Patel MC; Chesnokov A; Nguyen HT; De La Cruz J; Spencer S; Campbell AP; Sinner M; Reid H; Garten R; Katz JM; Fry AM; Barnes J; Wentworth DE
    Euro Surveill; 2019 Jan; 24(3):. PubMed ID: 30670144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts.
    Mok CK; Lee HH; Lestra M; Nicholls JM; Chan MC; Sia SF; Zhu H; Poon LL; Guan Y; Peiris JS
    J Virol; 2014 Mar; 88(6):3568-76. PubMed ID: 24403592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
    Jones JC; Pascua PNQ; Fabrizio TP; Marathe BM; Seiler P; Barman S; Webby RJ; Webster RG; Govorkova EA
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8593-8601. PubMed ID: 32217734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses.
    Song MS; Pascua PN; Lee JH; Baek YH; Park KJ; Kwon HI; Park SJ; Kim CJ; Kim H; Webby RJ; Webster RG; Choi YK
    J Virol; 2011 Jul; 85(13):6275-86. PubMed ID: 21507962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.
    Koszalka P; Tilmanis D; Roe M; Vijaykrishna D; Hurt AC
    Antiviral Res; 2019 Apr; 164():91-96. PubMed ID: 30771405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds.
    Xu L; Zhao L; Che J; Zhang Q; Cao R; Li X
    Bioorg Med Chem; 2021 Dec; 52():116515. PubMed ID: 34839161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication and transcription activities of ribonucleoprotein complexes reconstituted from avian H5N1, H1N1pdm09 and H3N2 influenza A viruses.
    Ngai KL; Chan MC; Chan PK
    PLoS One; 2013; 8(6):e65038. PubMed ID: 23750226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.